Each VIAL contains 2mg
CJC 1295 shows amazing results at releasing growth hormone. CJC 1295 has the ability to increase growth hormone and IGF-I secretion in extremely large amounts with no increase in prolactin, leading to fat loss and increased protein synthesis.
Security policy (edit with Customer reassurance module)
Delivery policy (edit with Customer reassurance module)
Return policy (edit with Customer reassurance module)
CJC-1295 has shown some amazing results as a growth hormone releasing hormone (GHRH) analog. CJC-1295 has shown the ability to increase growth hormone and IGF-I secretion, in very large amounts. Recent research studies have shown that CJC - 1295 stimulates GH and IGF-1 Secretion, and will keep a steady increase of HGH and IGF-1 with no increase in prolactin, leading to intense fat loss, and increases protein synthesis.
CJC 1295 DAC
A long acting Growth Hormone Releasing Hormone, which causes the anterior pituitary to release more growth hormone. GHRH is released in pulses in the body, which alternate with corresponding pulses of somatostatin (growth-hormone inhibiting-hormone).
Clinical Research was first conducted for CJC-1295 during the mid-2000s. The objective of the peptide was to treat visceral fat deposits in obese patients, by increasing levels of exogenous hgH that are presumed to increase lipolysis (fat loss). The clinical research was ultimately successful for most research subjects.
Ghrelin, released from the gut, which circulates and acts as a hunger hormone, has synergistic activity in the body with GHRH and also suppresses somatostatin to make way for the GHRH pulse. Studies shows that combining a GHRP-6 or GHRP 2 with CJC-1295 DAC , significantly increase the release of GH and IGF-1 production without an increase in prolactin.